These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 6518675

  • 1. Excretion of Tamm-Horsfall glycoprotein in renal disease.
    Lynn KL, Marshall RD.
    Clin Nephrol; 1984 Nov; 22(5):253-7. PubMed ID: 6518675
    [Abstract] [Full Text] [Related]

  • 2. Human Tamm-Horsfall glycoprotein: urinary and plasma levels in normal subjects and patients with renal disease determined by a fully validated radioimmunoassay.
    Thornley C, Dawnay A, Cattell WR.
    Clin Sci (Lond); 1985 May; 68(5):529-35. PubMed ID: 3979015
    [Abstract] [Full Text] [Related]

  • 3. Relationship of abnormal Tamm-Horsfall glycoprotein localization to renal morphology and function.
    Chambers R, Groufsky A, Hunt JS, Lynn KL, McGiven AR.
    Clin Nephrol; 1986 Jul; 26(1):21-6. PubMed ID: 3524927
    [Abstract] [Full Text] [Related]

  • 4. Correlation between urinary excretion of Tamm-Horsfall protein and sodium chloride in endemic nephropathy.
    Cvorisćec D, Stavljenić A.
    J Trace Elem Electrolytes Health Dis; 1988 Dec; 2(4):205-7. PubMed ID: 2980817
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of therapy for cast nephropathy: failure of colchicine to alter urinary Tamm Horsfall glycoprotein excretion in normal subjects.
    Cairns HS, Dawnay A, Woolfson RG, Unwin RJ.
    Exp Nephrol; 1994 Dec; 2(4):257-8. PubMed ID: 8069661
    [Abstract] [Full Text] [Related]

  • 6. Quantitation of proteinuria by use of single random spot urine collection.
    Chahar OP, Bundella B, Chahar CK, Purohit M.
    J Indian Med Assoc; 1993 Apr; 91(4):86-7. PubMed ID: 8409488
    [Abstract] [Full Text] [Related]

  • 7. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
    Matsuda H, Hayashi K, Saruta T.
    J Hum Hypertens; 2003 Apr; 17(4):271-6. PubMed ID: 12692572
    [Abstract] [Full Text] [Related]

  • 8. THE EXCRETION RATE OF TAMM-HORSFALL URINARY MUCOPROTEIN IN NORMALS AND IN PATIENTS WITH RENAL DISEASE.
    MCKENZIE JK, PATEL R, MCQUEEN EG.
    Australas Ann Med; 1964 Feb; 13():32-9. PubMed ID: 14122199
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical significance of determination of urinary albumin, beta 2 microglobulin and Tamm-Horsfall protein in diabetics].
    Yu M, Zhu YQ.
    Zhonghua Nei Ke Za Zhi; 1991 Jun; 30(6):354-6, 383. PubMed ID: 1914672
    [Abstract] [Full Text] [Related]

  • 10. Urinary excretion of Tamm-Horsfall protein and epidermal growth factor in chronic nephropathy.
    Torffvit O, Jørgensen PE, Kamper AL, Holstein-Rathlou NH, Leyssac PP, Poulsen SS, Strandgaard S.
    Nephron; 1998 Jun; 79(2):167-72. PubMed ID: 9647496
    [Abstract] [Full Text] [Related]

  • 11. Urine insulin in renal disease.
    Spitz IM, Rubenstein AH, Bersohn I, Wright AD, Lowy C.
    J Lab Clin Med; 1970 Jun; 75(6):998-1005. PubMed ID: 5421082
    [No Abstract] [Full Text] [Related]

  • 12. Significance of urinary excretion of fibrin degradation products during treatment of glomerulonephritis.
    Michielsen P, Roels L, Vanrenterghem Y, Boel A, van Damme B, Vermylen J.
    Clin Nephrol; 1976 Mar; 5(3):105-13. PubMed ID: 1261101
    [Abstract] [Full Text] [Related]

  • 13. Protein-to-creatinine ratio in spot urine samples as a predictor of quantitation of proteinuria.
    Xin G, Wang M, Jiao LL, Xu GB, Wang HY.
    Clin Chim Acta; 2004 Dec; 350(1-2):35-9. PubMed ID: 15530457
    [Abstract] [Full Text] [Related]

  • 14. An improved radioimmunoassay for urinary Tamm-Horsfall glycoprotein. Investigation and resolution of factors affecting its quantification.
    Dawnay AB, Thornley C, Cattell WR.
    Biochem J; 1982 Sep 15; 206(3):461-5. PubMed ID: 7150257
    [Abstract] [Full Text] [Related]

  • 15. Decreased urinary concentration of Tamm-Horsfall protein is associated with development of renal failure and cardiovascular death within 20 years in type 1 but not in type 2 diabetic patients.
    Sejdiu I, Torffvit O.
    Scand J Urol Nephrol; 2008 Sep 15; 42(2):168-74. PubMed ID: 17907053
    [Abstract] [Full Text] [Related]

  • 16. Urinary excretion of dipeptidyl aminopeptidase i.v. in patients with renal diseases.
    Wolf G, Scherberich JE, Nowack A, Stein O, Schoeppe W.
    Clin Nephrol; 1990 Mar 15; 33(3):136-42. PubMed ID: 2323111
    [Abstract] [Full Text] [Related]

  • 17. [Clinical aspects and renal function in patients with endemic nephropathy].
    Bukvić D, Djukanović L, Janković S.
    Srp Arh Celok Lek; 2003 Mar 15; 131(1-2):10-6. PubMed ID: 14608855
    [Abstract] [Full Text] [Related]

  • 18. Elevated urinary excretion of endothelin-like immunoreactivity in children with renal disease is related to urine flow rate.
    Worgall S, Manz F, Kleschin K, Feth F, Rascher W.
    Clin Nephrol; 1994 Jun 15; 41(6):331-7. PubMed ID: 8076435
    [Abstract] [Full Text] [Related]

  • 19. Tamm-Horsfall protein in Balkan endemic nephropathy.
    Cvorisćec D, Stavljenić A, Radonić M.
    J Clin Chem Clin Biochem; 1985 Apr 15; 23(4):177-81. PubMed ID: 4009127
    [Abstract] [Full Text] [Related]

  • 20. Is morning urinary protein/creatinine ratio a reliable estimator of 24-hour proteinuria in patients with glomerulonephritis and different levels of renal function?
    Morales JV, Weber R, Wagner MB, Barros EJ.
    J Nephrol; 2004 Apr 15; 17(5):666-72. PubMed ID: 15593033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.